Trevena, Inc.

  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
  • Pipeline
    • Overview
    • TRV250
    • TRV734
    • TRV045
    • TRV027
  • Products
    • OLINVYK™ (oliceridine) injection
  • Medical Affairs
    • Investigator-Initiated Trials
    • Contact Medical Information
  • Publications
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • Financial Info
    • Stock Info
    • Resources
    • Governance
  • Careers
  • Contact
    • Contact Medical Information
    • Whistleblower Hotline

Press Releases

Investors

Investors

  • Overview
  • Press Releases
  • Events & Presentations
    • Presentations
    • IR Calendar
  • Financial Info
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Stock Info
    • Quote
    • Analyst Coverage
  • Resources
    • Email Alerts
    • Contacts
    • FAQ
  • Governance
    • Overview
    • Management Team
    • Board of Directors
    • Governance Documents

Trevena, Inc. Announces Proposed Underwritten Offering of Common Stock

Sep 10, 2015 4:00pm EDT

Trevena Announces Presentations at PAINWeek® 2015

Sep 08, 2015 7:00am EDT

Trevena Announces Positive Results from Phase 2b Study of TRV130 in Acute Postoperative Pain

Aug 31, 2015 4:01pm EDT

Trevena Reports Second Quarter 2015 Financial Results and Provides a Corporate Update

Aug 11, 2015 7:00am EDT

Trevena CEO to Present at the 2015 Wedbush PacGrow Healthcare Conference

Aug 04, 2015 7:00am EDT

Trevena Appoints Yacoub Habib as Senior Vice President, Business Development and Corporate Planning

Jul 20, 2015 7:00am EDT

Trevena Added to Russell 3000®, Russell 2000®, and Russell Global Indexes

Jun 29, 2015 7:00am EDT

Trevena Announces Poster Presentation of Data for Delta Receptor Compound TRV250 at American Headache Society 57th Annual Scientific Meeting

Jun 18, 2015 4:00pm EDT

Trevena CEO to Present at the 2015 JMP Securities Life Sciences Conference

Jun 17, 2015 7:00am EDT

Trevena Granted Key U.S. Composition of Matter Patent for TRV734

Jun 02, 2015 7:00am EDT
RSS
  • Prev
    • 1...
    • 11
    • 12
    • 13
    • 14
    • 15
    • 16
    • 17
    • 18
    • 19
    • 20
    • ...26
    Next
    • Email Alerts
    • Tear Sheet
    • Contacts
    • RSS News Feed
    © 2021 Trevena, Inc. All Rights Reserved.
    Privacy Policy Terms of Use Disclaimer Sitemap